{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:10:37Z","timestamp":1773076237178,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"BBSRC CASE AWARD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12917-015-0598-z","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T12:54:39Z","timestamp":1449147279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney"],"prefix":"10.1186","volume":"11","author":[{"given":"L.","family":"Pelligand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Suemanotham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. N.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Seewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Syme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"key":"598_CR1","doi-asserted-by":"crossref","unstructured":"Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999;96(13):7563\u20138.","DOI":"10.1073\/pnas.96.13.7563"},{"issue":"5","key":"598_CR2","first-page":"480","volume":"15","author":"G Giovanni","year":"2002","unstructured":"Giovanni G, Giovanni P. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects? J Nephrol. 2002;15(5):480\u20138.","journal-title":"J Nephrol"},{"issue":"7504","key":"598_CR3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","volume":"330","author":"J Hippisley-Cox","year":"2005","unstructured":"Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case\u2013control analysis. B M J. 2005;330(7504):1366.","journal-title":"B M J"},{"issue":"1","key":"598_CR4","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajpcell.2001.281.1.C1","volume":"281","author":"RC Harris","year":"2001","unstructured":"Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol. 2001;281(1):F1\u201311.","journal-title":"Am J Physiol"},{"key":"598_CR5","first-page":"163","volume-title":"Clinical Physiology of Acid\u2013base and Electrolyte Disorders","author":"B Rose","year":"2001","unstructured":"Rose B, Post T. Effects of hormones on the renal function. In: Rose BD, Post TD, editors. Clinical Physiology of Acid\u2013base and Electrolyte Disorders, vol. 2001. Fifthth ed. New York: McGraw-Hill Publishers; 2001. p. 163\u2013238.","edition":"Fifth"},{"issue":"5","key":"598_CR6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10024001-0041-2","volume":"4","author":"KN Khan","year":"2001","unstructured":"Khan KN, Stanfield KM, Dannenberg A, Seshan SV, Baergen RN, Baron DA, et al. Cyclooxygenase-2 expression in the developing human kidney. Pediatr Dev Pathol. 2001;4(5):461\u20136.","journal-title":"Pediatr Dev Pathol"},{"issue":"5","key":"598_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/019262339802600504","volume":"26","author":"KN Khan","year":"1998","unstructured":"Khan KN, Venturini CM, Bunch RT, Brassard JA, Koki AT, Morris DL, et al. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol. 1998;26(5):612\u201320.","journal-title":"Toxicol Pathol"},{"issue":"4 Pt 2","key":"598_CR8","first-page":"F460","volume":"272","author":"M Komhoff","year":"1997","unstructured":"Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM. Localization of cyclooxygenase-1 and \u22122 in adult and fetal human kidney: implication for renal function. Am J Physiol. 1997;272(4 Pt 2):F460\u2013468.","journal-title":"Am. J. Physiol."},{"issue":"3","key":"598_CR9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0014-5793(99)01088-1","volume":"457","author":"F Nantel","year":"1999","unstructured":"Nantel F, Meadows E, Denis D, Connolly B, Metters KM, Giaid A. Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly. FEBS Lett. 1999;457(3):475\u20137.","journal-title":"FEBS Lett"},{"issue":"2","key":"598_CR10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)38195-9","volume":"289","author":"F Catella-Lawson","year":"1999","unstructured":"Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 1999;289(2):735\u201341.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"598_CR11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.ki.5002192","volume":"71","author":"CM Hao","year":"2007","unstructured":"Hao CM, Breyer MD. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int. 2007;71(11):1105\u201315.","journal-title":"Kidney Int"},{"issue":"5","key":"598_CR12","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/j.1523-1755.2005.00676.x","volume":"68","author":"DO Stichtenoth","year":"2005","unstructured":"Stichtenoth DO, Marhauer V, Tsikas D, Gutzki FM, Frolich JC. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. Kidney Int. 2005;68(5):2197\u2013207.","journal-title":"Kidney Int"},{"issue":"5","key":"598_CR13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2885.2010.01166.x","volume":"33","author":"VB Schmid","year":"2010","unstructured":"Schmid VB, Seewald W, Lees P, King JN. In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study. J Vet Pharmacol Ther. 2010;33(5):444\u201352.","journal-title":"J Vet Pharmacol Ther"},{"issue":"4","key":"598_CR14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/jvp.12107","volume":"37","author":"L Pelligand","year":"2014","unstructured":"Pelligand L, King JN, Hormazabal V, Toutain PL, Elliott J, Lees P. Differential pharmacokinetics and pharmacokinetic\/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation. J Vet Pharmacol Ther. 2014;37(4):354\u201366.","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"598_CR15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3565(25)39304-3","volume":"243","author":"KA Kirchner","year":"1987","unstructured":"Kirchner KA. Indomethacin antagonizes furosemide\u2019s intratubular effects during loop segment microperfusion. J Pharmacol Exp Ther. 1987;243(3):881\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"598_CR16","unstructured":"Kocheval D, Scott M: Drugs affecting renal function and fluid-electrolyte balance. In Veterinary Pharmacology and Therapeutics, Ninth Edition, Eds Riviere, JE, Papich MG, Wiley Blackwell Publishers. 2009: 656\u2013659."},{"issue":"4","key":"598_CR17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.RES.37.4.464","volume":"37","author":"WA Corsini","year":"1975","unstructured":"Corsini WA, Hook JB, Bailie MD. Control of renin secretion in the dog. Effects of furosemide on the vascular and macula densa receptors. Circ Res. 1975;37(4):464\u201370.","journal-title":"Circ Res"},{"issue":"1","key":"598_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.26.1.137","volume":"26","author":"XR He","year":"1995","unstructured":"He XR, Greenberg SG, Briggs JP, Schnermann J. Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion. Hypertension. 1995;26(1):137\u201342.","journal-title":"Hypertension"},{"issue":"1","key":"598_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1172\/JCI200318018","volume":"112","author":"J Peti-Peterdi","year":"2003","unstructured":"Peti-Peterdi J, Komlosi P, Fuson AL, Guan Y, Schneider A, Qi Z, et al. Luminal NaCl delivery regulates basolateral PGE2 release from macula densa cells. J Clin Invest. 2003;112(1):76\u201382.","journal-title":"J Clin Invest"},{"issue":"1","key":"598_CR20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1755.2001.00466.x","volume":"59","author":"B Mann","year":"2001","unstructured":"Mann B, Hartner A, Jensen BL, Kammerl M, Kramer BK, Kurtz A. Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int. 2001;59(1):62\u20138.","journal-title":"Kidney Int"},{"key":"598_CR21","first-page":"415","volume-title":"Clinical Physiology of Acid\u2013base and Electrolyte Disorders","author":"B Rose","year":"2001","unstructured":"Rose B, Post T. Hypovolemic states. In: Rose BD, Post TD, editors. Clinical Physiology of Acid\u2013base and Electrolyte Disorders, vol. 2001. Fifthth ed. New York: McGraw-Hill Publishers; 2001. p. 415\u201346.","edition":"Fifth"},{"issue":"2\u20133","key":"598_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000063782","volume":"12","author":"K Schumacher","year":"2002","unstructured":"Schumacher K, Castrop H, Strehl R, de Vries U, Minuth WW. Cyclooxygenases in the collecting duct of neonatal rabbit kidney. Cell Physiol Biochem. 2002;12(2\u20133):63\u201374.","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"598_CR23","doi-asserted-by":"crossref","first-page":"F19","DOI":"10.1152\/ajpcell.00120.2003","volume":"285","author":"V Campean","year":"2003","unstructured":"Campean V, Theilig F, Paliege A, Breyer M, Bachmann S. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Am J Physiol. 2003;285(1):F19\u201332.","journal-title":"Am J Physiol"},{"issue":"1-2","key":"598_CR24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.etp.2009.09.006","volume":"63","author":"M Meskell","year":"2011","unstructured":"Meskell M, Ettarh R. Immunohistochemical localisation of renal cyclooxygenase-1 expression in non-steroidal anti-inflammatory drug-treated mice. Exp Toxicol Pathol. 2011;63(1-2):39\u201342.","journal-title":"Exp Toxicol Pathol"},{"issue":"6","key":"598_CR25","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","volume":"94","author":"RC Harris","year":"1994","unstructured":"Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94(6):2504\u201310.","journal-title":"J Clin Invest"},{"issue":"5","key":"598_CR26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/01.ASN.0000124673.79934.24","volume":"15","author":"KL Therland","year":"2004","unstructured":"Therland KL, Stubbe J, Thiesson HC, Ottosen PD, Walter S, Sorensen GL, et al. Cycloxygenase-2 is expressed in vasculature of normal and ischemic adult human kidney and is colocalized with vascular prostaglandin E2 EP4 receptors. J Am Soc Nephrol. 2004;15(5):1189\u201398.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"598_CR27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-3565(25)31023-2","volume":"203","author":"PA Friedman","year":"1977","unstructured":"Friedman PA, Roch-Ramel F. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat. J Pharmacol Exp Ther. 1977;203(1):82\u201391.","journal-title":"J Pharmacol Exp Ther"},{"key":"598_CR28","first-page":"258","volume-title":"Clinical Physiology of Acid\u2013base and Electrolyte Disorders","author":"B Rose","year":"2001","unstructured":"Rose B, Post T. Regulation of the effective circulating volume. In: Rose BD, Post TD, editors. Clinical Physiology of Acid\u2013base and Electrolyte Disorders. Fifthth ed. New York: McGraw-Hill Publishers; 2001. p. 258\u201384.","edition":"Fifth"},{"issue":"1","key":"598_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/01.HYP.3.1.59","volume":"3","author":"V Sreenivasan","year":"1981","unstructured":"Sreenivasan V, Walker B, Krasney J, Mookerjee B, Venuto R. Role of endogenous prostaglandins in volume expansion and during furosemide infusion in conscious dogs. Hypertension. 1981;3(1):59\u201366.","journal-title":"Hypertension"},{"issue":"1","key":"598_CR30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1090-0233(98)80039-7","volume":"155","author":"S Yu","year":"1998","unstructured":"Yu S, Morris JG. Plasma aldosterone concentration of cats. Vet J. 1998;155(1):63\u20138.","journal-title":"Vet J"},{"issue":"2","key":"598_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2460\/ajvr.71.2.241","volume":"71","author":"RE Jepson","year":"2010","unstructured":"Jepson RE, Vallance C, Syme HM, Elliott J. Assessment of urinary N-acetyl-beta-D-glucosaminidase activity in geriatric cats with variable plasma creatinine concentrations with and without azotemia. Am J Vet Res. 2010;71(2):241\u20137.","journal-title":"Am J Vet Res"},{"issue":"4","key":"598_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004424-199304000-00012","volume":"28","author":"JA Jakobsen","year":"1993","unstructured":"Jakobsen JA, Nossen JO, Jorgensen NP, Berg KJ. Renal tubular effects of diuretics and X-ray contrast media. A comparative study of equimolar doses in healthy volunteers. Invest Radiol. 1993;28(4):319\u201324.","journal-title":"Invest Radiol"},{"issue":"3","key":"598_CR33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1258\/la.2011.010153","volume":"45","author":"L Pelligand","year":"2011","unstructured":"Pelligand L, Lees P, Elliott J. Development and validation of a timed urinary collection system for use in the cat. Lab Anim. 2011;45(3):196\u2013203.","journal-title":"Lab Anim"},{"key":"598_CR34","volume-title":"Studies of the Epidemiology and Aetiology of Systemic Hypertension in the Cat","author":"H Syme","year":"2003","unstructured":"Syme H. Studies of the Epidemiology and Aetiology of Systemic Hypertension in the Cat. London: London Royal Veterinary College; 2003."},{"issue":"2\u20133","key":"598_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcpa.2006.06.001","volume":"135","author":"A Hayes","year":"2006","unstructured":"Hayes A, Scase T, Miller J, Murphy S, Sparkes A, Adams V. COX-1 and COX-2 expression in feline oral squamous cell carcinoma. J Comp Pathol. 2006;135(2\u20133):93\u20139.","journal-title":"J Comp Pathol"},{"issue":"5","key":"598_CR36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1939-1676.2007.tb03063.x","volume":"21","author":"DA Heller","year":"2007","unstructured":"Heller DA, Fan TM, de Lorimier LP, Charney SC, Barger AM, Tannehill-Gregg SH, et al. In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells. J Vet Intern Med. 2007;21(5):1048\u201355.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"598_CR37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0022-3565(24)39157-8","volume":"294","author":"M Sabbatini","year":"2000","unstructured":"Sabbatini M, Vitaioli L, Baldoni E, Amenta F. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2000;294(3):948\u201354.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0598-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T17:06:01Z","timestamp":1748711161000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1746-6148\/11\/296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1186\/s12917-015-0598-z","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"296"}}